{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:20:56Z","timestamp":1790371256878,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0114060","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T20:29:58Z","timestamp":1417552198000},"page":"e114060","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":65,"title":["Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development"],"prefix":"10.1371","volume":"9","author":[{"given":"Anne Taraldsen","family":"Heldal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir Egil","family":"Eide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Romi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jone Furlund","family":"Owe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1212\/WNL.0b013e3181ad53c2","article-title":"Seropositive myasthenia gravis: a nationwide epidemiologic study","volume":"73","author":"AT Heldal","year":"2009","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1468-1331.2010.03089.x","article-title":"Myasthenia gravis requiring pyridostigmine treatment in a national population cohort","volume":"17","author":"JB Andersen","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/WCO.0b013e3283572588","article-title":"Myasthenia and the neuromuscular junction","volume":"25","author":"NE Gilhus","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"A Vincent","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00005-011-0158-6","article-title":"Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?","volume":"60","author":"F Baggi","year":"2012","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1073\/pnas.74.7.3090","article-title":"Modulation of acetylcholine receptor by antibody against the receptor","volume":"74","author":"S Heinemann","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1749-6632.1987.tb51301.x","article-title":"The membrane attack complex of complement at the endplate in myasthenia gravis","volume":"505","author":"AG Engel","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.54.2.474","article-title":"Mechanism of block of nicotinic acetylcholine receptor channels by purified IgG from seropositive patients with myasthenia gravis","volume":"54","author":"K Jahn","year":"2000","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.2012.06789.x","article-title":"Antibodies identified by cell-based assays in myasthenia gravis and associated diseases","volume":"1274","author":"A Vincent","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"W Hoch","year":"2001","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.autrev.2013.03.005","article-title":"Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis","volume":"12","author":"S Mori","year":"2013","journal-title":"Autoimmun Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"B Zhang","year":"2012","journal-title":"Arch Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"O Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"A Pevzner","year":"2012","journal-title":"J Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/08916931003602130","article-title":"Clinical aspects of myasthenia explained","volume":"43","author":"JJ Verschuuren","year":"2010","journal-title":"Autoimmunity"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"MN Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11940-004-0034-3","article-title":"Myasthenic Crisis","volume":"6","author":"JF Kirmani","year":"2004","journal-title":"Curr Treat Options Neurol"},{"key":"ref18","first-page":"327","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"70","author":"A Jaretzki 3rd","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/08916930903541208","article-title":"Diagnostic use of autoantibodies in myasthenia gravis","volume":"43","author":"MI Leite","year":"2010","journal-title":"Autoimmunity"},{"key":"ref20","first-page":"33","article-title":"Antibody specificity in myasthenia gravis","volume":"25","author":"A Vincent","year":"1988","journal-title":"Monogr Allergy"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1749-6632.1987.tb51285.x","article-title":"Humoral pathogenesis of myasthenia gravis","volume":"505","author":"DB Drachman","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp.74.8.1105","article-title":"Evidence of underdiagnosis of myasthenia gravis in older people","volume":"74","author":"A Vincent","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref23","article-title":"Does change in AChR antibody level correlate with clinical change in MG?","author":"DB Sanders","year":"2013","journal-title":"Muscle Nerve"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/clinchem\/43.5.824","article-title":"Modified and improved anti-acetylcholine receptor (AchR) antibody assay: comparison of analytical and clinical performance with conventional anti-AChR antibody assay","volume":"43","author":"B Ferrero","year":"1997","journal-title":"Clin Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1074\/jbc.M110.164848","article-title":"Extending half-life by indirect targeting of the neonatal Fc receptor (FcRn) using a minimal albumin binding domain","volume":"286","author":"JT Andersen","year":"2011","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.0.CO;2-E","article-title":"Sample size and optimal designs for reliability studies","volume":"17","author":"SD Walter","year":"1998","journal-title":"Stat Med"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Kleinbaum DG, Klein M, Pryor ER (2010) Logistic regression: a self-learning text. New York: Springer. xvii, 701 p. p.","DOI":"10.1007\/978-1-4419-1742-3"},{"key":"ref28","first-page":"360","article-title":"Understanding interobserver agreement: the kappa statistic","volume":"37","author":"AJ Viera","year":"2005","journal-title":"Fam Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/mus.21185","article-title":"Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite","volume":"38","author":"TM Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/jnnp.2006.109488","article-title":"Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology","volume":"78","author":"N Tsinzerling","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1590\/0004-282X20130108","article-title":"The myasthenic patient in crisis: an update of the management in Neurointensive Care Unit","volume":"71","author":"DA Godoy","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/WCO.0b013e328357a829","article-title":"Autoimmune mechanisms in myasthenia gravis","volume":"25","author":"P Cavalcante","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.2009.197632","article-title":"The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome","volume":"82","author":"P Maddison","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3988\/jcn.2011.7.4.173","article-title":"Treatment of myasthenia gravis based on its immunopathogenesis","volume":"7","author":"JY Kim","year":"2011","journal-title":"J Clin Neurol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","article-title":"Guidelines for treatment of autoimmune neuromuscular transmission disorders","volume":"17","author":"GO Skeie","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"E Tuzun","year":"2013","journal-title":"Autoimmun Rev"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0114060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T13:24:03Z","timestamp":1598534643000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0114060"}},"subtitle":[],"editor":[{"given":"G\u00fcher","family":"Saruhan-Direskeneli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,2]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0114060","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,2]]}}}